3.22.2 html 175 251 1 false 77 0 false 11 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfFinancialPosition CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Statements 2 false false R3.htm 100020 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfFinancialPositionParenthetical CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - CONSOLIDATED STATEMENTS OF PROFIT AND LOSS AND OTHER COMPREHENSIVE LOSS Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfProfitAndLossAndOtherComprehensiveLoss3 CONSOLIDATED STATEMENTS OF PROFIT AND LOSS AND OTHER COMPREHENSIVE LOSS Statements 4 false false R5.htm 100050 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Statements 5 false false R6.htm 100060 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfCashFlow CONSOLIDATED STATEMENTS OF CASH FLOW Statements 6 false false R7.htm 100070 - Disclosure - General information and reorganization transactions Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureGeneralInformationAndReorganizationTransactions General information and reorganization transactions Notes 7 false false R8.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100090 - Disclosure - Critical estimates and judgments Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCriticalEstimatesAndJudgments Critical estimates and judgments Notes 9 false false R10.htm 100100 - Disclosure - Revenue from contracts with customers Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRevenueFromContractsWithCustomers Revenue from contracts with customers Notes 10 false false R11.htm 100110 - Disclosure - Key management compensation Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureKeyManagementCompensation Key management compensation Notes 11 false false R12.htm 100120 - Disclosure - Income tax Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureIncomeTax Income tax Notes 12 false false R13.htm 100130 - Disclosure - (Loss)/earnings per share Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureLossearningsPerShare (Loss)/earnings per share Notes 13 false false R14.htm 100140 - Disclosure - Inventories Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureInventories Inventories Notes 14 false false R15.htm 100150 - Disclosure - Accounts receivable Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureAccountsReceivable Accounts receivable Notes 15 false false R16.htm 100160 - Disclosure - Cash and cash equivalents Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCashAndCashEquivalents Cash and cash equivalents Notes 16 false false R17.htm 100170 - Disclosure - Stockholder's equity Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureStockholdersEquity Stockholder's equity Notes 17 false false R18.htm 100180 - Disclosure - Accounts payable and accrued liabilities Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureAccountsPayableAndAccruedLiabilities Accounts payable and accrued liabilities Notes 18 false false R19.htm 100190 - Disclosure - Contingent liabilities and contingent assets Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureContingentLiabilitiesAndContingentAssets Contingent liabilities and contingent assets Notes 19 false false R20.htm 100200 - Disclosure - Commitments Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCommitments Commitments Notes 20 false false R21.htm 100210 - Disclosure - Related party transactions Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRelatedPartyTransactions Related party transactions Notes 21 false false R22.htm 100220 - Disclosure - Risk management overview Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRiskManagementOverview Risk management overview Notes 22 false false R23.htm 100230 - Disclosure - Subsequent Events Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 23 false false R24.htm 100240 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 24 false false R25.htm 100250 - Disclosure - General Information and Reorganization Transactions (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureGeneralInformationAndReorganizationTransactionsTables General Information and Reorganization Transactions (Tables) Tables 25 false false R26.htm 100260 - Disclosure - Revenue from Contracts with Customers (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRevenueFromContractsWithCustomersTables Revenue from Contracts with Customers (Tables) Tables 26 false false R27.htm 100270 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 27 false false R28.htm 100280 - Disclosure - Income tax (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureIncomeTaxTables Income tax (Tables) Tables http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureIncomeTax 28 false false R29.htm 100290 - Disclosure - (Loss)/Earnings per Share (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureLossearningsPerShareTables (Loss)/Earnings per Share (Tables) Tables 29 false false R30.htm 100300 - Disclosure - Inventories (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureInventoriesTables Inventories (Tables) Tables http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureInventories 30 false false R31.htm 100310 - Disclosure - Accounts Receivable (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureAccountsReceivableTables Accounts Receivable (Tables) Tables 31 false false R32.htm 100320 - Disclosure - Cash and Cash Equivalents (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCashAndCashEquivalentsTables Cash and Cash Equivalents (Tables) Tables 32 false false R33.htm 100330 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureAccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables 33 false false R34.htm 100340 - Disclosure - Commitments (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCommitmentsTables Commitments (Tables) Tables http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCommitments 34 false false R35.htm 100350 - Disclosure - Related Party Transactions (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRelatedPartyTransactionsTables Related Party Transactions (Tables) Tables 35 false false R36.htm 100360 - Disclosure - Risk Management Overview (Tables) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRiskManagementOverviewTables Risk Management Overview (Tables) Tables 36 false false R37.htm 100380 - Disclosure - General Information and Reorganization Transaction - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureGeneralInformationAndReorganizationTransactionAdditionalInformationDetails General Information and Reorganization Transaction - Additional Information (Details) Details 37 false false R38.htm 100400 - Disclosure - General Information and Reorganization Transactions - Schedule of Number of Shares Issued (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureGeneralInformationAndReorganizationTransactionsScheduleOfNumberOfSharesIssuedDetails General Information and Reorganization Transactions - Schedule of Number of Shares Issued (Details) Details 38 false false R39.htm 100410 - Disclosure - Summary of Significant Accounting Policies - Summary of Consolidated Subsidiaries (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfConsolidatedSubsidiariesDetails Summary of Significant Accounting Policies - Summary of Consolidated Subsidiaries (Details) Details 39 false false R40.htm 100420 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 40 false false R41.htm 100430 - Disclosure - Summary of Significant Accounting Policies - Functional and Presentation Currency (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndPresentationCurrencyDetails Summary of Significant Accounting Policies - Functional and Presentation Currency (Details) Details 41 false false R42.htm 100440 - Disclosure - Summary of Significant Accounting Policies - Disclosure of Effect of Changes in Foreign Exchange Rates (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesDisclosureOfEffectOfChangesInForeignExchangeRatesDetails Summary of Significant Accounting Policies - Disclosure of Effect of Changes in Foreign Exchange Rates (Details) Details 42 false false R43.htm 100450 - Disclosure - Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue from Contracts with Customers (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRevenueFromContractsWithCustomersScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue from Contracts with Customers (Details) Details 43 false false R44.htm 100460 - Disclosure - Revenue from Contracts with Customers - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRevenueFromContractsWithCustomersAdditionalInformationDetails Revenue from Contracts with Customers - Additional Information (Details) Details 44 false false R45.htm 100470 - Disclosure - Key Management Compensation - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureKeyManagementCompensationAdditionalInformationDetails Key Management Compensation - Additional Information (Details) Details 45 false false R46.htm 100480 - Disclosure - Income Tax - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetails Income Tax - Additional Information (Details) Details 46 false false R47.htm 100490 - Disclosure - Income Tax - Reconciliation of Income Taxes at Statutory Rates (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureIncomeTaxReconciliationOfIncomeTaxesAtStatutoryRatesDetails Income Tax - Reconciliation of Income Taxes at Statutory Rates (Details) Details 47 false false R48.htm 100500 - Disclosure - Income Tax - Summary of Net Deferred Tax Asset (Liability) (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureIncomeTaxSummaryOfNetDeferredTaxAssetLiabilityDetails Income Tax - Summary of Net Deferred Tax Asset (Liability) (Details) Details 48 false false R49.htm 100510 - Disclosure - Income Tax - Summary of Temporary Differences (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureIncomeTaxSummaryOfTemporaryDifferencesDetails Income Tax - Summary of Temporary Differences (Details) Details 49 false false R50.htm 100520 - Disclosure - (Loss)/Earnings per Share - Schedule of (Loss)/Earnings Per Share (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureLossearningsPerShareScheduleOfLossearningsPerShareDetails (Loss)/Earnings per Share - Schedule of (Loss)/Earnings Per Share (Details) Details 50 false false R51.htm 100530 - Disclosure - (Loss)/Earnings per Share - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureLossearningsPerShareAdditionalInformationDetails (Loss)/Earnings per Share - Additional Information (Details) Details 51 false false R52.htm 100540 - Disclosure - (Loss)/Earnings per Share - Schedule of Diluted (Loss)/Earnings Per Share (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureLossearningsPerShareScheduleOfDilutedLossearningsPerShareDetails (Loss)/Earnings per Share - Schedule of Diluted (Loss)/Earnings Per Share (Details) Details 52 false false R53.htm 100550 - Disclosure - Inventories - Summary of Inventories (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails Inventories - Summary of Inventories (Details) Details 53 false false R54.htm 100560 - Disclosure - Accounts Receivable - Summary of Accounts Receivable (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails Accounts Receivable - Summary of Accounts Receivable (Details) Details 54 false false R55.htm 100570 - Disclosure - Cash and Cash Equivalents - Schedule of Cash and Cash Equivalents (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails Cash and Cash Equivalents - Schedule of Cash and Cash Equivalents (Details) Details 55 false false R56.htm 100580 - Disclosure - Cash and Cash Equivalents - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCashAndCashEquivalentsAdditionalInformationDetails Cash and Cash Equivalents - Additional Information (Details) Details 56 false false R57.htm 100590 - Disclosure - Stockholder's Equity - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails Stockholder's Equity - Additional Information (Details) Details 57 false false R58.htm 100600 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureAccountsPayableAndAccruedLiabilitiesScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) Details 58 false false R59.htm 100610 - Disclosure - Contingent Liabilities and Contingent Assets - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureContingentLiabilitiesAndContingentAssetsAdditionalInformationDetails Contingent Liabilities and Contingent Assets - Additional Information (Details) Details 59 false false R60.htm 100620 - Disclosure - Commitments - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetails Commitments - Additional Information (Details) Details 60 false false R61.htm 100630 - Disclosure - Commitments - Schedule of Commitments for Minimum Lease Payments (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureCommitmentsScheduleOfCommitmentsForMinimumLeasePaymentsDetails Commitments - Schedule of Commitments for Minimum Lease Payments (Details) Details 61 false false R62.htm 100640 - Disclosure - Related Party Transactions - Summary of Related Party Payables (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRelatedPartyTransactionsSummaryOfRelatedPartyPayablesDetails Related Party Transactions - Summary of Related Party Payables (Details) Details 62 false false R63.htm 100650 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 63 false false R64.htm 100660 - Disclosure - Risk Management Overview - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRiskManagementOverviewAdditionalInformationDetails Risk Management Overview - Additional Information (Details) Details 64 false false R65.htm 100670 - Disclosure - Risk Management Overview - Disclosure of Monetary Assets and Liabilities Denominated In Foreign Currencies (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureRiskManagementOverviewDisclosureOfMonetaryAssetsAndLiabilitiesDenominatedInForeignCurrenciesDetails Risk Management Overview - Disclosure of Monetary Assets and Liabilities Denominated In Foreign Currencies (Details) Details 65 false false R66.htm 100680 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.viraxbiolabs.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 66 false false All Reports Book All Reports vrax-20220331.htm vrax-20220331.xsd vrax-20220331_cal.xml vrax-20220331_def.xml vrax-20220331_lab.xml vrax-20220331_pre.xml vrax-ex12_1.htm vrax-ex12_2.htm vrax-ex13_1.htm vrax-ex13_2.htm img132924985_0.jpg img132924985_1.jpg img132924985_10.jpg img132924985_11.jpg img132924985_12.jpg img132924985_13.jpg img132924985_14.jpg img132924985_15.jpg img132924985_2.jpg img132924985_3.jpg img132924985_4.jpg img132924985_5.jpg img132924985_6.jpg img132924985_7.jpg img132924985_8.jpg img132924985_9.jpg http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full http://xbrl.sec.gov/dei/2021q4 true true